Valuation : Apex Biotechnology Corp.

Market Cap 3.11B 98.68M 84.86M 79.82M 72.86M 136M 9.33B 137M 946M 366M 4.78B 371M 362M 15.22B P/E 2024
23.7x
P/E 2025 18.8x
Enterprise Value 2.58B 81.73M 70.29M 66.11M 60.35M 113M 7.73B 113M 784M 303M 3.96B 307M 300M 12.61B EV / Sales 2024
1.37x
EV / Sales 2025 1.29x
Free-Float
58.42%
Yield 2024
3.99%
Yield 2025 4.27%
1 day-2.01%
1 week-0.78%
Current month-0.78%
1 month-0.94%
3 months+2.92%
6 months+7.82%
Current year+4.11%
1 week 31.7
Extreme 31.7
32.5
1 month 29.6
Extreme 29.6
32.55
Current year 28
Extreme 28
33.1
1 year 28
Extreme 28
38.7
3 years 26
Extreme 26
44.45
5 years 22.45
Extreme 22.45
44.45
10 years 17.3
Extreme 17.3
44.7
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 2011-01-17
Chief Administrative Officer - -
Director TitleAgeSince
Chairman - 2011-01-17
Director/Board Member - 2011-01-17
Director/Board Member - 2018-05-24
Change 5-day change 1-year change 3-year change Capi.($)
-2.01%-0.78%+2.26%+15.69% 100M
-0.63%-0.58%+12.29%+9.46% 12.69B
-1.74%-1.60%+12.56%+28.76% 6.92B
-1.78%+3.21% - - 6.54B
-3.19%-12.75%+22.39%+12.67% 5.89B
-3.40%-0.93%-21.51%+49.41% 5.04B
-0.93%-1.66%-30.95%-21.24% 3.79B
-2.76%-0.12%+37.78%-13.33% 2.09B
+0.70%-5.27%-5.74%+119.89% 1.69B
-2.09%-4.39%+45.93%-18.01% 1.65B
Average -1.78%-0.47%+8.33%+20.37% 4.64B
Weighted average by Cap. -1.71%+0.43%+7.38%+17.77%

Financials

2024 2025
Net sales 1.85B 58.7M 50.48M 47.48M 43.34M 81.07M 5.55B 81.33M 563M 218M 2.84B 220M 216M 9.06B 1.94B 61.64M 53.01M 49.86M 45.51M 85.12M 5.83B 85.4M 591M 229M 2.99B 231M 226M 9.51B
Net income 128M 4.06M 3.49M 3.28M 3M 5.6M 384M 5.62M 38.91M 15.04M 196M 15.23M 14.9M 626M 163M 5.16M 4.44M 4.18M 3.81M 7.13M 488M 7.15M 49.51M 19.14M 250M 19.39M 18.96M 796M
Net Debt -476M -15.08M -12.97M -12.2M -11.14M -20.83M -1.43B -20.89M -145M -55.91M -730M -56.63M -55.4M -2.33B -535M -16.95M -14.57M -13.71M -12.51M -23.4M -1.6B -23.48M -163M -62.82M -821M -63.64M -62.25M -2.61B
Logo Apex Biotechnology Corp.
APEX BIOTECHNOLOGY CORP is a Taiwan-based company principally engaged in the research, development, manufacture and distribution of testing strips, electrode testing strips and tester suites. The Company primarily provides testing strips and monitoring systems, including blood glucose monitoring systems, uric acid monitoring systems, pesticide residue detection systems, lactate monitoring systems and hemachrome testing systems, among others. Its blood glucose monitoring systems and uric acid monitoring systems are mainly used by patients, doctors and nurses in hospitals and clinics. The Company distributes its products in domestic market and to overseas markets, including the Americas, Europe and the rest of Asia.
Employees
-
Date Price Change Volume
26-09-08 NT$31.15 -1.74% 135,360
26-09-07 NT$31.70 -2.01% 262,718
26-09-04 NT$32.35 +0.31% 246,259
26-09-03 NT$32.25 0.00% 159,208
26-09-02 NT$32.25 +0.16% 131,033

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1733 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!